A large investment of at least US$3.9 billion needed to meet the World Health Organization’s (WHO) target for the elimination of Hepatitis C virus (HCV) in Pakistan could deliver huge benefits in terms of lives saved and reduced ill health, according to University of Bristol led research published in The Lancet Global Health. Pakistan has one…
Tag: Hepatitis C
News: Class-action lawsuit filed in Nevada alleging hepatitis C care inaccessible to people in prison
In the United States, a federal class-action lawsuit was filed last month alleging that people incarcerated in Department of Corrections facilities in the state of Nevada do not have adequate access to direct-acting antivirals (DAAs), the standard of care for the treatment and cure of chronic hepatitis C. According to an article in the Las…
Research: Improvements in screening, prevention and treatment required to meet global hep C elimination targets
New research published in The Lancet suggests that if improvements in public health interventions for hepatitis C are made, the global elimination targets of reducing new infections by 80% could be met in 2030, and the target to reduce mortality by 65% could be met in 2032. The study modelled the impact of four public…
Research: Needle/syringe programs highly cost-effective for hep C prevention in UK
According to research published in Addiction, needle and syringe programs are a highly cost-effective means of preventing hepatitis C transmission among people who inject drugs. Investment in such programming, the results show, could save millions of pounds in treatment costs in the United Kingdom (UK). Using data from three UK cities, the researchers estimated the…
Research: Modelling for microelimination in 3 regions of Switzerland
New research published in Swiss Medical Weekly models the current epidemiology of hepatitis C virus in three regions of Switzerland, identifying increases in diagnosis and treatment rates that may be required to achieve the goals of the Swiss Hepatitis Strategy. According to the study, elimination of chronic hepatitis C infection in eastern (region of St…
News: AbbVie and MPP complete licensing agreement to ensure access to G/P in 99 low and middle-income countries
AbbVie and MPP complete a new licensing agreement to ensure access to G/P in 99 low- and middle-income (LMIC) countries and territories
Opinion: Micro-elimination potentially a “big deal” for hep C and HIV services
Following the British HIV Association’s (BHIVA) proposal of ambitious targets for eliminating hepatitis C in people living with HIV in the UK, a new editorial in The Lancet looks at some the benefits of microelimination strategies. “Focusing elimination efforts in smaller affected populations allows for quick, efficient targeting of treatment and prevention services,” the article…
News: Millions flock to free tests as Egypt seeks to eradicate hepatitis C
Reuters published a story this week on a massive campaign to identify and treat patients suffering from hepatitis C infection in Egypt. The aim of the campaign is to screen the entire adult population — or 50 million people — in an attempt to eliminate the disease from the country by 2022. The campaign, Reuters…
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 